Several investigations have confirmed that H19 is over-expressed in bladder [97], glioma [98], thyroid [99], gastric [100] and breast cancers [101] through various mechanisms, including chromosomal abnormalities, transcription factor binding, and epigenetic alterations. This evidence concerns the gene H19 and breast carcinoma.